🔥🐔 BizChicken 🐔🔥
Companies Similar to Sagimet Biosciences Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
AnaptysBio, Inc.
Imsidolimab, Rosnilimab, ANB032
Anaptys Bio, Inc. is a clinical stage biotechnology company focused on developing therapeutic product candidates for inflammation and immuno-oncology indications. Their products target dermatological inflammatory diseases and other human inflammatory conditions.
Symbol: ANAB
Recent Price: $13.22
Industry: Biotechnology
CEO: Mr. Daniel R. Faga
Sector: Healthcare
Employees: 117
Address: 10770 Wateridge Circle, San Diego, CA 92121-5801
Phone: 858 362 6295
Last updated: 2024-12-31
Hepion Pharmaceuticals, Inc.
Rencofilstat
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing drug therapies for chronic liver diseases, particularly through the development of Rencofilstat, a cyclophilin inhibitor aimed at treating non-alcoholic steatohepatitis (NASH) and reducing liver fibrosis and tumors.
About | Leadership | About | About | About | News | Contact | Careers | About | About | About
Symbol: HEPA
Recent Price: $0.43
Industry: Biotechnology
CEO: Mr. John Patrick Brancaccio CPA
Sector: Healthcare
Employees: 22
Address: 399 Thornall Street, Edison, NJ 08837
Phone: 732 902 4000
Leadership
- John P. Brancaccio, Interim Chief Executive Officer, Interim Chief Financial Officer, and Chairman of the Board
Last updated: 2024-12-31
Lexicon Pharmaceuticals, Inc.
Sotagliflozin, LX9211
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical products, with drugs like Sotagliflozin and LX9211 under development for heart failure, type 1 diabetes, and neuropathic pain.
About | Foundation | Leadership | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: LXRX
Recent Price: $0.72
Industry: Biotechnology
CEO: Dr. Michael Exton Ph.D.
Sector: Healthcare
Employees: 285
Address: 2445 Technology Forest Boulevard, The Woodlands, TX 77381
Phone: 281 863 3000
Leadership
- Brian Corrigan, Senior Vice President, Regulatory and Quality Assurance
- Brian Crum, Senior Vice President and General Counsel
- Lisa DeFrancesco, Vice President, Investor Relations and Corporate Communications
- Mike Exton, Ph.D., Chief Executive Officer and Director
- Tom Garner, Senior Vice President and Chief Commercial Officer
- Craig Granowitz, MD, PhD, Senior Vice President and Chief Medical Officer
- Alan Main, PhD, Executive Vice President, Innovation and Chemical Sciences
- Wendy McDermott, Senior Vice President, Human Resources
- Kristen Alexander, Vice President, Finance and Accounting
- Phillip Banks, MS, FRS, Vice President, Biostatistics and Data Management
- Kyle Burt, Vice President, Information Operations
- Amy Carroll, Ph.D., Vice President, Medical Affairs
- Melinda Francini, Vice President, Value and Access
- Desiree Gendron, Vice President, Sales and Training
- Suma Gopinathan, Ph.D., Vice President, Clinical Development
- Rachel Martens, Vice President, Partnerships and Corporate Strategy
- Nicole Moore, Vice President, Legal
- Tracy Newbold, Vice President, Clinical Operations
- Godfried Owusu-Ababio, Vice President, Technical Operations
- Rob Scala, Vice President, Business Planning and Commercial Operations
- Carrie Siragusa, Vice President, Marketing
- Dixon Terry, Vice President, Compliance
- Raymond Debbane, Chairman
- Philippe J. Amouyal,
- Samuel L. Barker, PhD,
- Robert J. Lefkowitz, MD,
- Christopher J. Sobecki,
- Diane E. Sullivan,
- Judith L. Swain, MD,
Last updated: 2024-12-31
Syndax Pharmaceuticals, Inc.
SNDX-5613, SNDX-6352 (axatilimab), Entinostat
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.
Symbol: SNDX
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Michael A. Metzger M.B.A.
Sector: Healthcare
Employees: 184
Address: 35 Gatehouse Drive, Waltham, MA 02451
Phone: 781 419 1400
Last updated: 2024-12-31
Abivax SA American Depositary Shares
obefazimod
ABIVAX Société Anonyme is a clinical-stage biotechnology company developing therapeutics to modulate the immune response for chronic inflammatory diseases. Their lead drug candidate, obefazimod, is in Phase 3 clinical trials for ulcerative colitis.
About | Vision/Values | History | Leadership | Contact | About | About
Symbol: ABVX
Recent Price: $7.05
Industry: Biotechnology
CEO: Mr. Marc M. P. de Garidel M.B.A.
Sector: Healthcare
Employees: 62
Address: 7-11 boulevard Haussmann, Paris, null 75009
Phone: 33 1 53 83 09 63
Leadership
- Marc de Garidel, MBA, Chief Executive Officer
- Didier Blondel, EVP, Chief Financial Officer & Board Secretary
- Fabio Cataldi, MD, Chief Medical Officer
- Ida Hatoum, Chief People Officer, Chief Compliance Officer
- David Zhang, PhD, Chief Strategy Officer
- Pierre Courteille, Pharmacist, MBA, Chief Business Officer
- Didier Scherrer, PhD, Chief Scientific Officer
- Jérôme Denis, PhD, EVP, Process Development & Manufacturing
- Nadège Briancon-Eris, PhD, Senior Vice President, Global Head of Program Management
- Sylvie Grégoire, PharmD, Chair of the Board
- Corinna zur Bonsen-Thomas, Co-founder and CEO of RetInSight; Former General Counsel at Baxter/Baxalta International
- Philippe Pouletty, MD, Founder of Abivax; Managing Partner of Truffle Capital
- June Lee, MD FACCP, Venture Partner at 5AM Ventures
- Kinam Hong, MD, MBA, CFA, Partner at the Crossover Fund Sofinnova
- Troy Ignelzi, CFO of Rapport Therapeutics
- Camilla Soenderby, Board Member of BB Biotech, F2G, and Affibody; Member of Novo Holdings Advisory Group; Industrial Advisor for EQT
- Mary Mantock, Senior Vice President, Global Head of Regulatory Affairs
- Hema Keshava, Senior Vice President, Finance
- Cristina Damatarca, MD, PgD, Senior Vice President, Global Head of Drug Safety and Pharmacovigilance
- Patrick Malloy, Senior Vice President, Investor Relations
- Douglas Jacobstein, MD, Senior Vice President, Global Head of Clinical Development
- Jennifer Fine, ScD, Senior Vice President, Global Head of HEOR and RWE
- Kevin Shan, PhD, Vice President, Global Head of Biometrics
- Chris Rabbat, PhD, Vice President, Global Head of Medical Affairs
- Ana Sharma, MPH, Vice President, Global Head of Quality
- Sophie LaCourrege, Vice President, HR Business Partner, Engagement and Culture
Last updated: 2024-12-31
Akebia Therapeutics, Inc.
Vadadustat
Akebia Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutics for kidney disease patients, with a lead product vadadustat for treating anemia due to chronic kidney disease.
Symbol: AKBA
Recent Price: $1.85
Industry: Biotechnology
CEO: Mr. John P. Butler MBA
Sector: Healthcare
Employees: 167
Address: 245 First Street, Cambridge, MA 02142
Phone: 617 871 2098
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
Coherus BioSciences, Inc.
UDENYCA
Coherus Bio Sciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. It markets UDENYCA and develops various biosimilar and immuno-oncology products.
Symbol: CHRS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Dennis M. Lanfear
Sector: Healthcare
Employees: 306
Address: 333 Twin Dolphin Drive, Redwood City, CA 94065
Phone: 650 649 3530
Last updated: 2024-12-31
Cyclacel Pharmaceuticals, Inc.
Fadraciclib, CYC140, Sapacitabine, Seliciclib
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of medicines for treating cancer and other proliferative diseases. The company's key development programs include fadraciclib, CYC140, Sapacitabine, and seliciclib, targeting various forms of cancer and other conditions.
Symbol: CYCC
Recent Price: $0.37
Industry: Biotechnology
CEO: Mr. Spiro George Rombotis
Sector: Healthcare
Employees: 12
Address: 200 Connell Drive, Berkeley Heights, NJ 07922
Phone: 908 517 7330
Last updated: 2024-12-31
Fortress Biotech, Inc.
Pharmaceutical and Biotechnology Products
Fortress Biotech, Inc., is a biopharmaceutical company focused on developing and commercializing a range of dermatology products and late-stage product candidates for various medical conditions.
About | About | About | Leadership | Directors | About | About | Contact | Careers | Careers | Careers | About | About | About
Symbol: FBIO
Recent Price: $2.18
Industry: Biotechnology
CEO: Dr. Lindsay Allan Rosenwald
Sector: Healthcare
Employees: 186
Address: 1111 Kane Concourse, Bay Harbor Islands, FL 33154
Phone: 781 652 4500
Leadership
- Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer
- Michael S. Weiss, Executive Vice Chairman, Strategic Development
- David Jin, Chief Financial Officer and Head of Corporate Development
- George Avgerinos, Ph.D., Senior Vice President, Biologics Operations
- Samuel Berry, General Counsel and Corporate Secretary
- Jimmie Harvey, Jr., M.D., Director
- Malcolm Hoenlein, Director
- Dov Klein, Director
- J. Jay Lobell, Director
- Kevin L. Lorenz, J.D., Director
- Lucy Lu, M.D., Director
Last updated: 2024-12-31
Forte Biosciences, Inc.
FB-102
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Dallas, Texas, developing the FB-102 program for autoimmune diseases like vitiligo and alopecia areata.
Symbol: FBRX
Recent Price: $21.14
Industry: Biotechnology
CEO: Dr. Paul A. Wagner Ph.D.
Sector: Healthcare
Employees: 11
Address: 3060 Pegasus Park Drive, Dallas, TX 75247
Phone: 310 618 6994
Last updated: 2024-12-31
FibroGen, Inc.
Roxadustat, Pamrevlumab
Fibro Gen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics to treat serious unmet medical needs, including treatments for anemia, idiopathic pulmonary fibrosis, and Duchenne muscular dystrophy.
Symbol: FGEN
Recent Price: $0.53
Industry: Biotechnology
CEO: Mr. Thane Wettig
Sector: Healthcare
Employees: 486
Address: 409 Illinois Street, San Francisco, CA 94158
Phone: 415 978 1200
Last updated: 2024-12-31
Onconetix, Inc.
Entadfi
Onconetix, Inc. is a biotechnology and pharmaceutical company focused on developing and commercializing transformative therapies to address global health challenges. The company’s products include Entadfi for benign prostatic hyperplasia and various innovative vaccine candidates.
Symbol: ONCO
Recent Price: $0.44
Industry: Biotechnology
CEO: Dr. Ralph Schiess Ph.D.
Sector: Healthcare
Employees: 12
Address: 201 East Fifth Street, Cincinnati, OH 45202
Phone: 513 620 4101
Last updated: 2024-12-31
Sana Biotechnology, Inc.
N/A
Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.
Symbol: SANA
Recent Price: $1.61
Industry: Biotechnology
CEO: Dr. Steven D. Harr M.D.
Sector: Healthcare
Employees: 328
Address: 188 East Blaine Street, Seattle, WA 98102
Phone: 206 701 7914
Last updated: 2024-12-31
Cassava Sciences, Inc.
simufilam
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead product candidate, simufilam, is a small molecule drug, recently completed Phase 2b clinical trial. The company also develops Sava Dx, a diagnostic to detect Alzheimer's disease.
Symbol: SAVA
Recent Price: $2.40
Industry: Biotechnology
CEO: Mr. Richard Jon Barry
Sector: Healthcare
Employees: 29
Address: 7801 North Capital of Texas Highway, Austin, TX 78731
Phone: 512 501 2444
Last updated: 2024-12-31
Sagimet Biosciences Inc.
Denifanstat
Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics called fatty acid synthase (FASN) inhibitors for diseases caused by dysfunctional lipid metabolism pathways. Its lead drug candidate, Denifanstat, targets nonalcoholic steatohepatitis and acne. The company is also working on FASN inhibitors for cancer treatment.
About | Contact | Careers | About | Directors | About | About | Contact | About | About | About | About | Contact | ESG | Events | About | Careers
Symbol: SGMT
Recent Price: $4.72
Industry: Biotechnology
CEO: Mr. David A. Happel
Sector: Healthcare
Employees: 8
Address: 155 Bovet Road, San Mateo, CA 94402
Phone: 650-561-8600
Leadership
- George Kemble, PhD, Executive Chairman of the Board
- David Happel, Chief Executive Officer
- Anne Phillips, MD,
- Beth Seidenberg, MD,
- Elizabeth Grammer, Esq,
- Jennifer Jarrett,
- Merdad Parsey, MD, PhD,
- Paul Hoelscher,
- Tim Walbert,
Last updated: 2024-12-31
Synlogic, Inc.
Synthetic Biotic Medicines
Synlogic, Inc. is a clinical-stage biopharmaceutical company focused on the development of synthetic biotic medicines to treat metabolic and immunological diseases. The company's pipeline includes drug candidates for conditions such as phenylketonuria, homocystinuria, enteric hyperoxaluria, and solid tumors and lymphoma.
Symbol: SYBX
Recent Price: $1.40
Industry: Biotechnology
CEO: Mr. Antoine Awad
Sector: Healthcare
Employees: 6
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 401 9975
Last updated: 2024-12-31
Annovis Bio, Inc.
Buntanetap
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound, Buntanetap, is in clinical trials for various neurodegenerative disorders.
Symbol: ANVS
Recent Price: $5.08
Industry: Biotechnology
CEO: Dr. Maria L. Maccecchini Ph.D.
Sector: Healthcare
Employees: 6
Address: 1055 Westlakes Drive, Berwyn, PA 19312
Phone: 610 727 3913
Last updated: 2024-12-31
Denali Therapeutics Inc.
BIIB122/DNL151
Denali Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing therapeutic candidates for neurodegenerative diseases. Its pipeline includes treatments for Parkinson's disease, hunter syndrome, ALS, multiple sclerosis, and Alzheimer's disease. It collaborates with companies such as Takeda Pharmaceutical Company and Genentech, Inc.
Symbol: DNLI
Recent Price: $20.24
Industry: Biotechnology
CEO: Dr. Ryan J. Watts Ph.D.
Sector: Healthcare
Employees: 364
Address: 161 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 866 8548
Last updated: 2024-12-31
Lantheus Holdings, Inc.
DEFINITY, Techne Lite, Xenon-133, Neurolite, Cardiolite, Thallium-201, Gallium-67, AZEDRA, Automated Bone Scan Index, Cobalt (Co 57), RELISTOR
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.
Symbol: LNTH
Recent Price: $89.13
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Brian A. Markison
Sector: Healthcare
Employees: 834
Address: 331 Treble Cove Road, North Billerica, MA 01862
Phone: 978 671 8001
Leadership
- Brian Markison, Chief Executive Officer
- Paul Blanchfield, President
- Jeff Humphrey, MD, Chief Medical Officer
- Robert J. Marshall Jr., Chief Financial Officer
- Amanda Morgan, Chief Commercial Officer
- Daniel Niedzwiecki, Chief Administrative Officer, General Counsel and Corporate Secretary
- Jean-Claude Provost, MD, Chief Science Officer
- Jamie Spaeth, Chief People Officer
- Cheryl Ball, Senior Vice President, Strategy and Enterprise Planning
- Dorothy Barr, Senior Vice President, Manufacturing and Technical Operations
- Kim Brown, Chief Accounting Officer
- Lee Anne Howe, Chief Information Officer
- Linda Lennox, Chief of Staff & Vice President, Corporate Communications
- Joann Nestor, Senior Vice President, Legal Affairs
- Andrea Sabens, Vice President, Business Optimization
- Carol Walker, Senior Vice President, Quality
- Mary Anne Heino, Chairperson of the Board
- Minnie Baylor-Henry, Director
- Gérard Ber, PhD, Director
- Julie Eastland, Director
- Samuel Leno, Director
- Heinz Mäusli, Director
- Julie McHugh, Director
- Gary J. Pruden, Director
- James H. Thrall, MD, Director
Last updated: 2024-12-31